Human CAP1/CAP/CAP1-PEN ORF/cDNA clone-Lentivirus particle (NM_006367)

Cat. No.: vGMLP000656

Pre-made Human CAP1/CAP/CAP1-PEN Lentiviral expression plasmid for CAP1 lentivirus packaging, CAP1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.

Product information

Catalog No. Product Name lentivirus Grade lentivirus quantity
vGMLP000656 Human CAP1 Lentivirus particle Pilot Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
Research Grade 1.0E+8TU
5.0E+8TU
1.0E+9TU
GMP-like Grade inquiry
GMP Grade inquiry


Product Description

Catalog ID vGMLP000656
Gene Name CAP1
Accession Number NM_006367
Gene ID 10487
Species Human
Product Type Lentivirus particle (overexpression)
Insert Length 1428 bp
Gene Alias CAP,CAP1-PEN
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGCTGACATGCAAAATCTGGTAGAAAGATTGGAGAGGGCAGTGGGCCGCCTGGAGGCAGTATCTCATACCTCTGACATGCACCGTGGGTATGCAGACAGTCCTTCAAAAGCAGGAGCAGCTCCATATGTGCAGGCATTTGACTCGCTGCTTGCTGGTCCTGTGGCAGAGTACTTGAAGATCAGTAAAGAGATTGGGGGAGACGTGCAGAAACATGCGGAGATGGTCCACACAGGTTTGAAGTTGGAGCGAGCTCTGTTGGTTACAGCTTCTCAGTGTCAACAGCCAGCAGAAAATAAGCTTTCCGATTTGTTGGCACCCATCTCAGAGCAGATCAAAGAAGTGATAACCTTTCGGGAGAAGAACCGAGGCAGCAAGTTGTTTAATCACCTGTCAGCTGTCAGCGAAAGTATCCAGGCCCTGGGCTGGGTGGCTATGGCTCCCAAGCCTGGCCCTTATGTGAAAGAAATGAATGATGCCGCCATGTTTTATACAAACCGAGTCCTCAAAGAGTACAAAGATGTGGATAAGAAGCATGTAGACTGGGTCAAAGCTTATTTAAGTATATGGACAGAGCTGCAGGCTTACATTAAGGAGTTCCATACCACCGGACTGGCCTGGAGCAAAACGGGGCCTGTGGCAAAAGAACTGAGCGGACTGCCATCTGGACCCTCTGCCGGATCATGTCCTCCTCCCCCTCCACCATGCCCCCCTCCTCCCCCAGTCTCTACCATTTCATGCTCATATGAGTCTGCTTCCCGCTCATCACTGTTCGCGCAGATTAATCAGGGGGAGAGCATTACACATGCCCTGAAACATGTATCTGATGACATGAAGACTCACAAGAACCCTGCCCTGAAGGCTCAGAGTGGTCCAGTACGCAGTGGCCCCAAACCATTCTCTGCACCTAAACCCCAAACCAGCCCATCCCCCAAACGAGCCACAAAGAAGGAGCCAGCTGTACTTGAACTGGAGGGCAAGAAGTGGAGAGTGGAAAATCAGGAAAATGTTTCCAACCTGGTGATTGAGGACACAGAGCTGAAACAGGTGGCTTACATATACAAGTGTGTCAACACGACATTGCAAATCAAGGGCAAAATTAACTCCATTACAGTAGATAACTGTAAGAAACTTGGCCTGGTATTCGATGACGTGGTGGGCATTGTGGAGATAATCAACAGTAAGGATGTCAAAGTTCAGGTAATGGGTAAAGTGCCAACCATATCCATCAACAAAACAGATGGCTGCCATGCTTACCTGAGCAAGAATTCCCTGGATTGTGAAATAGTCAGTGCCAAATCTTCCGAGATGAATGTCCTCATTCCTACAGAAGGCGGTGACTTTAATGAATTCCCAGTTCCTGAGCAGTTCAAGACCCTATGGAACGGGCAGAAGTTGGTCACCACAGTGACAGAAATTGCTGGATAA
ORF Protein Sequence MADMQNLVERLERAVGRLEAVSHTSDMHRGYADSPSKAGAAPYVQAFDSLLAGPVAEYLKISKEIGGDVQKHAEMVHTGLKLERALLVTASQCQQPAENKLSDLLAPISEQIKEVITFREKNRGSKLFNHLSAVSESIQALGWVAMAPKPGPYVKEMNDAAMFYTNRVLKEYKDVDKKHVDWVKAYLSIWTELQAYIKEFHTTGLAWSKTGPVAKELSGLPSGPSAGSCPPPPPPCPPPPPVSTISCSYESASRSSLFAQINQGESITHALKHVSDDMKTHKNPALKAQSGPVRSGPKPFSAPKPQTSPSPKRATKKEPAVLELEGKKWRVENQENVSNLVIEDTELKQVAYIYKCVNTTLQIKGKINSITVDNCKKLGLVFDDVVGIVEIINSKDVKVQVMGKVPTISINKTDGCHAYLSKNSLDCEIVSAKSSEMNVLIPTEGGDFNEFPVPEQFKTLWNGQKLVTTVTEIAG

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector pGMLP000656 Human CAP1 Lentivirus plasmid




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.